A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

What’s surprising is the drug in question. Li has been dosing the mice with one of the GLP-1 agonist drugs—the suddenly-everywhere class of drugs that includes Ozempic, Wegovy, and Mounjaro ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

A new monthly weight loss drug, MariTide, helped people shed up to 20% of body weight in a Phase 2 trial—comparable to Wegovy ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic teeth" may involve tooth decay, sensitivity, and tooth loss. Dentists ...